Page last updated: 2024-11-02

phenobarbital and Carcinomatous Meningitis

phenobarbital has been researched along with Carcinomatous Meningitis in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research Excerpts

ExcerptRelevanceReference
"The lifetime risk of having epileptic seizures is profoundly increased in patients with cancer: about 20% of all patients with systemic cancer may develop brain metastases."2.48Epilepsy meets cancer: when, why, and what to do about it? ( Stupp, R; Weller, M; Wick, W, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weller, M1
Stupp, R1
Wick, W1

Reviews

1 review available for phenobarbital and Carcinomatous Meningitis

ArticleYear
Epilepsy meets cancer: when, why, and what to do about it?
    The Lancet. Oncology, 2012, Volume: 13, Issue:9

    Topics: Animals; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Causality; Comorbidity; Drug Inter

2012